F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 18,800 shares at $22.09 ($416K) on 2022-11-28, disclosed to the SEC on 2022-11-30.
Open-market sale of $416k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 9,400 | $208K | 49.9% |
| 2 | $22.18 | 9,400 | $208K | 50.1% |
| Total | $22.14 avg | 18,800 | $416K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |